Jennison Associates LLC Reduces Position in Teladoc Health, Inc. $TDOC

by · The Cerbat Gem

Jennison Associates LLC decreased its stake in shares of Teladoc Health, Inc. (NYSE:TDOC – Free Report) by 8.0% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 84,370 shares of the health services provider’s stock after selling 7,330 shares during the period. Jennison Associates LLC’s holdings in Teladoc Health were worth $735,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the stock. Teacher Retirement System of Texas increased its position in Teladoc Health by 5.7% during the second quarter. Teacher Retirement System of Texas now owns 26,592 shares of the health services provider’s stock worth $232,000 after buying an additional 1,431 shares in the last quarter. Y Intercept Hong Kong Ltd purchased a new position in Teladoc Health during the second quarter worth $2,722,000. Envestnet Asset Management Inc. acquired a new stake in shares of Teladoc Health during the second quarter worth $89,000. AlphaQuest LLC grew its position in shares of Teladoc Health by 768.2% in the second quarter. AlphaQuest LLC now owns 32,341 shares of the health services provider’s stock valued at $282,000 after purchasing an additional 28,616 shares during the period. Finally, Caitong International Asset Management Co. Ltd grew its position in shares of Teladoc Health by 8,192.0% in the second quarter. Caitong International Asset Management Co. Ltd now owns 8,292 shares of the health services provider’s stock valued at $72,000 after purchasing an additional 8,192 shares during the period. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Wall Street Analysts Forecast Growth

TDOC has been the subject of a number of recent analyst reports. Evercore ISI lowered their price objective on Teladoc Health from $9.00 to $8.00 and set an “in-line” rating for the company in a research report on Thursday. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Teladoc Health in a research report on Wednesday, October 8th. Zacks Research upgraded Teladoc Health from a “hold” rating to a “strong-buy” rating in a report on Friday, October 10th. Mizuho began coverage on Teladoc Health in a report on Friday, July 25th. They issued a “neutral” rating and a $10.00 target price on the stock. Finally, Citigroup lifted their target price on Teladoc Health from $9.50 to $10.50 and gave the company a “neutral” rating in a report on Tuesday, October 21st. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $9.73.

Get Our Latest Research Report on TDOC

Teladoc Health Trading Down 1.2%

Shares of TDOC opened at $8.64 on Friday. The stock’s 50-day moving average is $8.23 and its two-hundred day moving average is $7.71. The stock has a market cap of $1.53 billion, a PE ratio of -6.75 and a beta of 1.90. Teladoc Health, Inc. has a 12 month low of $6.35 and a 12 month high of $15.21. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.67 and a quick ratio of 2.58.

Teladoc Health (NYSE:TDOC – Get Free Report) last issued its quarterly earnings data on Wednesday, October 29th. The health services provider reported ($0.21) EPS for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.05. The company had revenue of $626.44 million for the quarter, compared to analysts’ expectations of $625.66 million. Teladoc Health had a negative return on equity of 10.49% and a negative net margin of 8.84%.The firm’s quarterly revenue was down 2.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.19) earnings per share. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. Equities analysts forecast that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Teladoc Health Profile

(Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Further Reading

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC – Free Report).